Targeting protein homeostasis holds potential to treat solid tumors and blood cancers

[News]

The success of proteasome inhibitors such as VELCADE® (bortezomib) and Kyprolis® (carfilzomib) for the treatment of multiple myeloma has shown that protein homeostasis, which is how cells...

More... (http://www.medicalnewstoday.com/releases/303570.php)